Diamyd Medical AB (publ) (STO:DMYD.B)

Diamyd Medical AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is September - August.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 24, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Market Capitalization	1,493	1,637	840	1,122	2,412	2,736
Market Cap Growth	-	94.98%	-25.12%	-53.50%	-11.83%	373.65%
Enterprise Value	1,174	1,475	762	929	2,218	2,654
Last Close Price	10.86	16.42	9.79	14.24	32.90	38.61
PE Ratio	-	-	-	-	40.17	281.77
PS Ratio	11575.56	12595.78	1538.11	2470.47	9533.21	8022.48
PB Ratio	4.60	11.22	4.96	5.23	12.74	37.74
P/TBV Ratio	4.60	11.22	4.96	5.23	12.75	37.85
P/FCF Ratio	-	-	-	-	-	183.59
P/OCF Ratio	-	-	-	-	-	162.07
EV/Sales Ratio	-	11346.68	1396.51	2045.78	8765.65	7783.43
EV/FCF Ratio	-6.85	-	-	-	-	178.12
Asset Turnover	0	0.00	0.00	0.00	0.00	0.00
Quick Ratio	11.00	3.41	6.66	7.59	12.37	4.37
Current Ratio	11.47	3.98	7.09	8.10	14.29	4.39
Return on Equity (ROE)	-67.16%	-96.32%	-60.49%	-51.29%	45.88%	14.36%
Return on Assets (ROA)	-36.38%	-45.14%	-32.74%	-32.80%	-36.95%	-25.49%
Return on Capital (ROIC)	-45.34%	-60.53%	-37.73%	-35.59%	-41.10%	-30.90%
Earnings Yield	-11.70%	-9.27%	-13.82%	-9.23%	2.49%	0.36%
FCF Yield	-11.48%	-8.38%	-14.57%	-11.40%	-4.71%	0.55%
Buyback Yield / Dilution	-14.01%	-20.98%	-2.29%	-9.65%	-0.90%	-5.81%

Updated May 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.